/assets/images/provider/photos/2818547.jpg)
October is Lewy Body Dementia (LBD) Awareness Month — an important time to raise recognition of a condition that is commonly underdiagnosed and often mistaken for Alzheimer’s disease or psychiatric illness. Early recognition can accelerate appropriate care, reduce avoidable medication risks, and connect patients and families with targeted support. Below is a clear, patient-friendly guide to what Lewy body dementia is, the symptoms people most often notice first, and how CNS Brain Center supports patients through diagnosis and integrated care. National Institute on Aging+1
Lewy body dementia (sometimes abbreviated LBD and also referred to clinically as dementia with Lewy bodies — DLB) is a progressive neurodegenerative disorder caused by abnormal deposits of a protein called alpha-synuclein (Lewy bodies) in brain cells. These deposits interfere with brain circuits that control thinking, movement, sleep, behavior, and autonomic functions (blood pressure, digestion, etc.). Because LBD affects multiple systems, its symptoms often overlap with Alzheimer’s disease and Parkinson’s disease, which can make diagnosis challenging. National Institute on Aging+1
LBD has a characteristic combination of features. The most important and commonly reported early or “core” symptoms include:
Most families notice non-memory symptoms first — vivid visual hallucinations, unusual nighttime behaviors (RBD), repeated falls or new slowness, or abrupt changes in alertness. Because memory loss may be mild early on, these “non-memory” changes often prompt the first conversation with a doctor. Unfortunately, because these signs overlap with psychiatric conditions and other dementias, LBD is frequently missed or misdiagnosed initially — underscoring the importance of an evaluation by a neurologist familiar with Lewy body disorders. National Institute on Aging+1
Diagnosis is clinical and often uses standardized criteria (history, cognitive testing, motor exam, sleep history), supported by brain imaging or polysomnography when indicated. Because medications commonly used for other dementias or psychiatric conditions can cause severe sensitivity or worsening in LBD (for example, certain antipsychotics), accurate diagnosis matters for safe treatment planning. Mayo Clinic+1
While there is currently no cure or disease-modifying therapy for LBD, research supports symptom-targeted interventions. Cholinesterase inhibitors (for example, rivastigmine) may help cognition and neuropsychiatric symptoms, and careful use of Parkinsonian medications can improve motor symptoms. Non-pharmacologic strategies (sleep hygiene, occupational therapy, caregiver education) are also central to care. Recent reviews summarize best practices for symptom management and emphasize multidisciplinary approaches. PMC+1
At CNS Center we understand that Lewy body dementia affects the whole person and the whole family. Our integrated Brain Center model brings neurology, neuropsychology, sleep medicine, physical therapy, neurorehabilitation, hyperbaric support services where appropriate, and allied care into coordinated, patient-centered plans. Here’s how we help:
If October’s awareness campaign raised questions for you, please reach out. At CNS Brain Center, our team specializes in diagnosing and managing Lewy body dementia with thoughtful, evidence-informed care and practical support for patients and families. To schedule an appointment or learn more about our LBD evaluation pathway, visit www.cns-center.com or call our office to speak with our care coordination team.
CNS Brain Center - Where science powers brain health and longevity.